
Human CardiovascularMAP® v 1.0
A 50-biomarker Multi-Analyte-Profile (MAP) combining analytes most commonly associated with cardiovascular disease. Like all RBM MAPs, it is used to identify useful patterns indicative of the effects of either disease or therapeutic intervention. RBM’s MAP approach provides investigators with a reliable platform and quantitative immunoassay data that can help discern biomarker patterns in a cost-effective, efficient process.Sample Volume Requirements
Mouse over each antigen to view its definition

